Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02671578Phase 4Completed
Phase 4, open-label, single-arm trial of nitrous oxide in anxiety disorder and pain. Primary endpoint: Bispectral Index at 2 hours. Started Nov 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02671578.